Company / Return on Assets (ROA)
CAPRICOR THERAPEUTICS, INC. Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-29.5%
FY2025
5-year range
-57.9% / -23.7%
FY2021-FY2025
Trend
-24.3%
vs FY2024
Sector context
#130 of 213
Health Care
What the data says
At -29.5%, CAPRICOR THERAPEUTICS, INC.'s return on assets (roa) ranks #130 of 213 in the Health Care sector. Return on Assets (ROA) has fluctuated over the past 10 years, ranging from -164.3% in FY2018 to 14.9% in FY2017.
Based on SEC 10-K filings.
-29.5% in FY2025 with a 5-year CAGR of +9.9%.
Improved from -38.0% to -29.5% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +28.4pp
- 5-Year Change
- +9.9pp
- 10-Year Change
- -
Sector benchmark
#130 of 213 in Health CareTop 61% of 213This company -29.5% Sector average -24.1%
▼
-22.2% below sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 24.3% year-over-year.
- Currently 5.4pp below the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2017.
- Lowest return on assets (roa) in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -29.5% | -24.3% |
| FY2024 | -23.7% | +37.4% |
| FY2023 | -38.0% | +34.5% |
| FY2022 | -57.9% | -19.6% |
| FY2021 | -48.4% | -22.8% |
| FY2020 | -39.5% | +71.1% |
| FY2019 | -136.7% | +16.8% |
| FY2018 | -164.3% | -1199.6% |
| FY2017 | 14.9% | +114.9% |
| FY2016 | -100.3% | -25.4% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026